AVE5026, a new hemisynthetic ultra-low-molecular-weight heparin for the prevention of venous thromboembolism in patients after total knee replacement surgery-TREK: a dose-ranging study - Lassen, MR; Dahl, OE; Mismetti, P (J Thromb Haemost, 2009)